Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Sao Paulo
04:04:00 2026-10-15 pm EDT
|
5-day change | 1st Jan Change | ||
| 9.230 BRL | +30.37% |
|
+1.88% | +1.10% |
| Market Cap | 1.13B 224M 200M 186M 169M 319M 21.26B 324M 2.24B 875M 11.09B 842M 824M 35.49B | P/E 2024 |
6.95x | P/E 2025 | 9.42x |
|---|---|---|---|---|---|
| Enterprise Value | 2.3B 456M 407M 378M 344M 647M 43.17B 659M 4.54B 1.78B 22.53B 1.71B 1.67B 72.08B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.2x |
| Free-Float |
32.86% | Yield 2024 |
8.86% | Yield 2025 | - |
| 1 day | +30.37% | ||
| 1 week | +1.88% | ||
| Current month | +24.56% | ||
| 1 month | +21.29% | ||
| 3 months | +36.54% | ||
| 6 months | +14.37% | ||
| Current year | +1.10% |
| 1 week | 8.79 |  | 9.42 |
| 1 month | 7 | | 9.42 |
| Current year | 6.11 | | 9.7 |
| 1 year | 6.11 | | 9.7 |
| 3 years | 3.4 | | 9.7 |
| 5 years | 2.92 | | 9.7 |
| 10 years | 2.87 | | 11.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 58 | 2010-04-20 |
| Director of Finance/CFO | 68 | 1992-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CHM | Chairman | 58 | 2008-04-02 |
| Director/Board Member | 91 | 2010-04-20 | |
| Director/Board Member | 62 | 2010-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/25 | Others | 1 | 0.0000% | - | ||
| 12/9/24 | Sell | 12,200 | 0.0099% | |||
| 12/9/24 | Sell | 12,400 | 0.0100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +30.37% | +1.88% | +30.55% | +147.45% | 225M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,077B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 612B | |
| +0.59% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 364B | |
| +2.37% | +5.47% | +32.67% | +48.87% | 353B | |
| +2.64% | +4.90% | +21.01% | +43.85% | 278B | |
| +3.24% | +4.25% | -0.31% | +15.71% | 251B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 230B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 190B | |
| Average | +4.54% | +3.06% | +34.47% | +70.94% | 385.67B | |
| Weighted average by Cap. | +1.74% | +3.42% | +38.51% | +71.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.15B 2.01B 1.8B 1.67B 1.52B 2.86B 191B 2.91B 20.07B 7.85B 99.51B 7.56B 7.4B 318B | 11.45B 2.27B 2.03B 1.88B 1.71B 3.22B 215B 3.28B 22.63B 8.85B 112B 8.52B 8.34B 359B |
| Net income | 115M 22.72M 20.28M 18.85M 17.15M 32.26M 2.15B 32.84M 226M 88.6M 1.12B 85.27M 83.47M 3.59B | 119M 23.58M 21.05M 19.56M 17.79M 33.48M 2.23B 34.08M 235M 91.94M 1.17B 88.49M 86.61M 3.73B |
| Net Debt | 1.02B 202M 180M 167M 152M 286M 19.11B 292M 2.01B 787M 9.97B 757M 741M 31.9B | 1.17B 231M 207M 192M 175M 328M 21.91B 334M 2.31B 902M 11.43B 868M 850M 36.59B |
Employees
7,077
Sector
Pharmaceuticals
Calendar
Oct. 27
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | R$9.230 | 0.00% | 237,600 |
| 26-10-14 | R$9.230 | +1.99% | 225,500 |
| 26-10-13 | R$9.050 | +0.22% | 213,900 |
| 26-10-09 | R$9.030 | -0.33% | 391,800 |
| 26-10-08 | R$9.060 | +2.26% | 270,800 |
- Stock Market
- Stocks
- PFRM3 Stock
Select your edition
All financial news and data tailored to specific country editions
